Toggle Main Menu Toggle Search

Open Access padlockePrints

Longitudinal changes in respiratory and upper limb function in a pediatric type III spinal muscular atrophy cohort after loss of ambulation

Lookup NU author(s): Robert Muni Lofra, Ruth Wake, Dr Anna Mayhew, Professor Chiara Marini Bettolo

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2021 Wiley Periodicals LLC.Introduction/Aims: Spinal muscular atrophy (SMA) type III is a relatively mild form of SMA. Few studies have investigated the changes in both respiratory and upper limb function within this population after loss of ambulation. The aim of this study was to assess change in percentage of predicted forced vital capacity (FVC% predicted) and change in the Revised Upper Limb Module (RULM) score in these patients throughout a 24-month period after loss of ambulation. Effect of scoliosis and its surgical correction, disease duration since loss of ambulation, weight, and height were also investigated. Methods: Retrospective analyses were performed on 24 nonambulant SMA III patients from data collected at two centers in the United Kingdom. Results: The FVC% predicted score showed a significant progressive deterioration of 17% over the 24-month period. Respiratory deterioration correlated significantly with age, weight, disease duration since loss of ambulation, and spinal correctional surgery. Longitudinal RULM data were available for 16 patients; a significant deterioration was observed with a mean decrease in score of 3 over 24 months. Age correlated negatively with RULM score, as did height and time since loss of ambulation. A significant positive correlation between FVC% predicted and RULM was demonstrated. Discussion: This study highlights how SMA type III patients have progressive deterioration of respiratory and upper limb function after loss of ambulation. Combining data from these assessments could provide insight into clinical progression, inform clinical trials, and provide assistance in managing disease progression expectations for patients.


Publication metadata

Author(s): Wolfe A, Scoto M, Milev E, Muni Lofra R, Abbott L, Wake R, Rohwer A, Main M, Baranello G, Mayhew A, Marini-Bettolo C, Muntoni F

Publication type: Article

Publication status: Published

Journal: Muscle and Nerve

Year: 2021

Volume: 64

Issue: 5

Pages: 545-551

Print publication date: 01/11/2021

Online publication date: 25/08/2021

Acceptance date: 21/08/2021

ISSN (print): 0148-639X

ISSN (electronic): 1097-4598

Publisher: John Wiley and Sons Inc

URL: https://doi.org/10.1002/mus.27404

DOI: 10.1002/mus.27404


Altmetrics

Altmetrics provided by Altmetric


Share